Importance Controlling myopia progression is of interest worldwide. Low-dose atropine eye
drops have slowed progression in children in East Asia. Objective To compare atropine …

Myopia has significantly risen in East and Southeast Asia, and the pathological outcomes of
this condition, such as myopic maculopathy and optic neuropathy linked to high myopia …

The prevalence of myopia is increasing across the world. Controlling myopia progression
would be beneficial to reduce adverse outcomes such as retinal detachment and myopic …

Myopia presents a formidable challenge, especially in children, where clinical management
involves the use of atropine and 7-methylxanthine, necessitating multiple doses, strong side …

Importance Clinical trial results of topical atropine eye drops for childhood myopia control
have shown inconsistent outcomes across short-term studies, with little long-term safety or …

Abstract Purpose The Myopia Outcome Study of Atropine in Children (MOSAIC) is an
investigator‐led, double‐masked, randomized controlled trial investigating the efficacy and …

The risk of eye diseases such as myopic macular degeneration increases with the level of
myopia, but there is no safe level of myopia and the burden of lower degrees of myopia …

Purpose To describe choroidal thickness measurements using a sequential deep learning
segmentation in adults who received childhood atropine treatment for myopia control …

Importance Treatments are needed to slow progression of or reduce incidence of myopia.
Objective To evaluate the efficacy and safety of daily 650-nm low-level red light (LLRL) for …

Myopia is becoming increasingly common in young generations all over the world, and it is
predicted to become the most common cause of blindness and visual impairment in later life …